LY 2979165

Drug Profile

LY 2979165

Alternative Names: LY2979165

Latest Information Update: 06 May 2016

Price : $50

At a glance

  • Originator Eli Lilly
  • Class
  • Mechanism of Action Metabotropic glutamate receptor 2 agonists; Metabotropic glutamate receptor 3 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Bipolar disorders

Most Recent Events

  • 06 May 2016 Chemical structure information added
  • 27 Apr 2016 Discontinued - Phase-I for Bipolar disorders (In volunteers) in Singapore & United Kingdom (PO)
  • 23 Nov 2010 Phase-I clinical trials in Bipolar disorders in Singapore (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top